Ongoing Clinical Research Trials

  1.  A Multi-Center, Double-Blind, Randomized Study Comparing the Combined Use of Interferon Beta-1a and Glatiramer Acetate to Either Agent Alone in Patients with Relapsing Remitting Multiple Sclerosis
    (CombiRx-Phase III)
    Principal Investigator: Bianca Weinstock-Guttman, MD
    Sponsor: NIH

  2. Interventions to Improve Memory in Patients with Multiple Sclerosis
    (AIMS2). 
    Principal Investigator:  Bianca Weinstock-Guttman, MD
    Sponsor:  NIH

  3. A Multi-Centered, Randomized, Double-Blind, Placebo Controlled Study Assessing the Add-On-Effect of Oral Steroids in Relapsing Remitting Multiple Sclerosis Subjects Treated with Glatiramer Acetate (GA)
    (ASSERT)
    Principal Investigator:  Bianca Weinstock-Guttman, MD 
    Sponsor:  Teva

  4. MyoRx in Multiple Sclerosis Patients with Chronic Pain 
    Principal Investigator:  Bianca Weinstock-Guttman, MD
    Sponsor:  Jog for the Jake

  5. A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy and Safety of Atorvastatin in Patients with Clinically Isolated Syndrome and High Risk of Conversion to Multiple Sclerosis (MS)
    (STAyCIS) 
    Principal Investigators: Bianca Weinstock-Guttman, MD
    Sponsor: NIH

  6. A Multi-Centered, Double-Blind, Randomized Start, Placebo Controlled, Parallel-Group Study to Assess Rasagiline as a Disease Modifying Therapy in Early Parkinson's Disease
    (ADAGIO)
    Principal Investigator:  Thomas Guttuso, MD 
    Sponsor:  Teva